By Kelley Weiss
Kansas City, MO – KU Medical Center will use $7.5 million in NIH funding to head an institution developing male contraceptive drugs. KU will work with researchers at seven universities under the five year grant. The medical center says this work is needed because many pharmaceutical companies have stopped male fertility research. Right now men only have two mainstream options for preventing pregnancy: vasectomy or using a condom. Researchers hope to develop non-hormonal, reversible drug treatments that are more effective than current options.